Science Problem · Mine for Science

🫁 Mine Lung Cancer Research — Earn SXOR

👥
People Affected

2,200,000 people impacted by this problem

🧩
Total Chunks

1,500,000 computation chunks to solve

🌐
Mine Free

Browser mining — no downloads or hardware needed

💰
Earn SXOR

Every solved chunk earns SXOR directly to your wallet

About This Research Problem

Lung cancer is the leading cause of cancer death worldwide — 1.8 million deaths per year. When caught at Stage I, 5-year survival is 61%. When caught at Stage IV (as most cases are), survival falls to 6%. The solution is early detection via blood-based biomarkers. Your compute runs genomic alignment and machine learning tasks that build the biomarker atlas researchers need to design a blood test that detects lung cancer before symptoms appear. Supported by the National Cancer Institute and MD Anderson Cancer Center.

How to Start Mining

1
Create Account

Free signup — 60 seconds

2
Select Problem

Choose this problem from the dashboard dropdown

3
Click Start

Mining begins immediately in your browser

Start mining lung cancer research now.

⚡ Create Free Account

Already have an account? Sign in →

Other Science Problems

🧬
Cancer Research

Contribute your computer's idle power to pancreatic cancer protein mapping.

💧
Clean Water

Help detect waterborne pathogens through distributed computing.

🌍
Climate Change

Run carbon capture optimization models in your browser.

🌬️
Air Pollution

Help trace sources of air pollution through distributed computing.

🕊️
Peace Conflict

Contribute to conflict pattern modeling research.

🧠
Parkinsons Disease

Contribute to Parkinson's disease alpha-synuclein protein mapping.

Als Disease

Contribute to ALS / Lou Gehrig's disease research.

🧬
Alzheimers Disease

55 million people have Alzheimer's disease — the number doubles every 20 years.

🔋
Multiple Sclerosis

Multiple sclerosis affects 2.

🌱
Childhood Leukemia

Pediatric ALL has 90% survival in wealthy countries — but resistance kills thousands annually.

💨
Cystic Fibrosis

CFTR modulators transformed CF for 90% of patients — but 10% have rare mutations with no approved therapy.